Perry Elliott

101.2k citations
522 papers · 37.9k indexed · 19 hit papers · h-index 97

Impact in

    • Cardiomyopathy and Myosin Studies
    • Cardiovascular Effects of Exercise
    • Cardiovascular Function and Risk Factors
    • Cardiac electrophysiology and arrhythmias
    • Cardiac pacing and defibrillation studies
    • Cardiac Arrhythmias and Treatments
    • Viral Infections and Immunology Research
  • Physiology top 0.2%
    • Lysosomal Storage Disorders Research

Papers in

Perry Elliott

502 papers receiving 36.9k citations

Hit Papers

Cardiac Involvement in Fabry Disease 2021 · 177 citations
177200020262008201750010001.5k2.0k2.5k

Peers

Perry Elliott
Comparison fields: 5 of 180
  • Cardiology and Cardiovascular Medicine 29.6k
  • Physiology 4.4k
  • Epidemiology 5.6k
  • Developmental Neuroscience 634
  • Radiology, Nuclear Medicine and Imaging 3.4k
Replace Toyoaki Murohara with:
Toyoaki Murohara Japan
Stephen E. Epstein United States
Joshua M. Hare United States
Magdi H. Yacoub United Kingdom
Gerhard Schüler Germany
William D. Edwards United States
Jeffrey A. Towbin United States
Michael H. Picard United States
Pieter A. Doevendans Netherlands
Jeffrey M. Isner United States
Perry Elliott relative to Toyoaki Murohara Japan Toyoaki Murohara's profile →
Citations per field
00.5×1.5×2.1×
Toyoaki Murohara · 1×
Citations per year

Countries citing papers authored by Perry Elliott

Since Specialization
Citations

This map shows the geographic impact of Perry Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Elliott more than expected).

Fields of papers citing papers by Perry Elliott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Elliott. The network helps show where Perry Elliott may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Perry Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Perry Elliott Line = papers co-authored together Perry Elliott links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20247
2 20242
3 20241
4 202425
5 20233
6 20234
7 202012
8
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Hit paper breakdown →
20142934
9 2013107
10
Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis
Hit paper breakdown →
2010689
11
Mutations in the Lamin A/C Gene Play a Major Role in Sudden Arrhythmic Death Syndrome
20101
12 201082
13
Heart Rhythm UK Familial Sudden Death Syndromes Statement Development Group. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement.
20081
14
Anderson-Fabry disease: An important differential diagnosis in patients with unexplained left ventricular hypertrophy
20061
15
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy - Reply
20020
16
Intronic and missense mutations within the LAMP-2 gene in Danon disease (X linked vacuolar cardiomyopathy and myopathy)
20021
17
Histological and immunohistochemical myocardial abnormalities in early familial dilated cardiomyopathy
20001
18
A de novo mutation of the troponin T gene in a patient with hypertrophic cardiomyopathy
20001
19
Computerised QT dispersion measurement and risk stratification in patients with hypertrophic cardiomyopathy
19971
20
Amiodarone and sudden death in hypertrophic cardiomyopathy
19970

About Perry Elliott

Perry Elliott is a scholar working on Cardiology and Cardiovascular Medicine, Developmental Neuroscience, Epidemiology, Physiology and Molecular Biology, having authored 522 papers that have together received 37.9k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (302 papers), Cardiovascular Effects of Exercise (151 papers), Cardiovascular Function and Risk Factors (95 papers), Viral Infections and Immunology Research (66 papers), Lysosomal Storage Disorders Research (52 papers), Trypanosoma species research and implications (49 papers), Cardiac pacing and defibrillation studies (46 papers) and Cardiac Arrhythmias and Treatments (42 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (29.6k citations), Physiology (4.4k citations), Epidemiology (5.6k citations), Developmental Neuroscience (634 citations) and Radiology, Nuclear Medicine and Imaging (3.4k citations). Perry Elliott has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include William J. McKenna, James Moon, Lorenzo Monserrat, Juan R. Gimeno, Philippe Charron, Claudio Rapezzi, Jens Mogensen, Giuseppe Limongelli, Franco Cecchi and Niall Mahon. Their work appears in journals such as European Heart Journal, Heart, Journal of the American College of Cardiology, Circulation and Journal of Cardiovascular Magnetic Resonance.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026